State of Alaska, Department of Revenue
Position in ETON — Eton Pharmaceuticals, Inc.
CIK 1370102
JUNEAU, AK
Position in ETON
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$251,336
+$79,984 QoQ
Shares Held
6,943
0.0% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#111
of 163 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ETON Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026State of Alaska, Department of Revenue holds $35,084,807 across 29 Drug Manufacturers - Specialty & Generic names. ETON ranks #22 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
18,264 | $9,895,982 | |
| 2 | ALKS |
Alkermes plc.
|
63,841 | $3,344,948 | |
| 3 | ZTS |
Zoetis Inc.
|
41,077 | $2,951,793 | |
| 4 | LQDA |
Liquidia Corp
|
23,136 | $1,844,633 | |
| 5 | VTRS |
Viatris Inc
|
114,105 | $1,811,987 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
9,852 | $1,660,456 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
40,151 | $1,647,395 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
32,585 | $1,515,527 |
All Filings in ETON
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $251,336 | 6,943 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $171,352 | 6,943 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $117,406 | 6,943 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $30,878 | 1,421 | Shares | Sole | 2025-10-24 | |
| No filing history on record for this holder in this stock. | ||||||